Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?

OBJECTIVE: The 340B Drug Pricing Program allows hospitals to purchase covered drugs at a discount and potentially generate profit if they are reimbursed at rates that exceed 340B acquisition prices. Disproportionate share hospitals (DSH) are eligible to participate in 340B if their DSH adjustment–a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulligan, Karen, Romley, John A., Myerson, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176719/
https://www.ncbi.nlm.nih.gov/pubmed/34082835
http://dx.doi.org/10.1186/s13104-021-05642-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176719/
https://www.ncbi.nlm.nih.gov/pubmed/34082835
http://dx.doi.org/10.1186/s13104-021-05642-4

Ejemplares similares